ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
AI醫療
657.977
-14.645
-2.18%
手動刷新
漲家數:
3
跌家數:
5
平家數:
- -
市盈率:
- -
高:
691.227
開:
672.842
低:
655.165
收:
672.622
成交量:
2.13億
成交額:
19.06億
市值:
1,869.76億
流通市值:
1,839.07億
資料載入中...
總覽
新聞資訊
《業績》微創機器人(02252.HK)全年虧損收窄至2.5億人民幣
阿斯达克财经
·
昨天
智雲健康(09955)發布年度業績 收入16.23億元 毛利7.75億元
智通财经
·
昨天
醫渡科技(02158)授權受託人根據股份獎勵計劃從市場購買股份
智通财经
·
昨天
中國臨床循證智能能力建設計劃啓動 醫渡智循亮相中關村論壇年會
智通财经
·
昨天
愛康醫療(01789.HK)3月26日耗資718.8萬港元回購119.4萬股
中金财经
·
昨天
阿里健康(00241)出現大手賣出110萬股,成交價$4.7,涉資517萬
阿斯达克财经
·
昨天
平安好醫生(01833)股價下跌7.451%,現價港幣$11.8
阿斯达克财经
·
昨天
「AI製藥」的晶泰控股扭虧虛與實
华尔街见闻
·
昨天
港股異動 | 微創機器人-B(02252)績前升逾3% 公司預計去年收入最高按年增長120%
智通财经
·
昨天
AI for Science第一股晶泰控股(2228.HK)首次盈利,AI」養蝦」時代迎來收網者
格隆汇
·
昨天
平安好醫生(01833)2025年報發出了一個關鍵信號
智通财经
·
昨天
【券商聚焦】中信建投:醫療器械板塊拐點來臨,26年業績改善個股存在業績估值修復機會
金吾财讯
·
昨天
晶泰控股(02228)首次全年盈利:稀缺「AI+機器人」平台進入價值兑現期
智通财经
·
昨天
愛康醫療(01789)發布年度業績 股東應占年度溢利3.39億元 按年增加23.8%
智通财经
·
03/25
平安好醫生去年經營利潤首次轉正 AI醫生年使用人數近1200萬人
澎湃新闻
·
03/25
平安好醫生2025年歸母利潤增長366.1%
国际金融报
·
03/25
XtalPi FY2025; revenue rises to CNY 803 million
Reuters
·
03/25
權益持倉超1.2萬億!「壽險頭雁」披露年報,鴻鵠基金首次「官宣」規模數據
华尔街见闻
·
03/25
阿里健康與諾華達成數字化慢病合作 共建慢性蕁麻疹院外管理新模式
人民财讯
·
03/25
不再「單飛」後,平安好醫生變強了
华尔街见闻
·
03/25
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1617/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1617\",,,,,undefined,":{"symbol":"BK1617","market":"HK","secType":"PLATE","nameCN":"AI醫療","latestPrice":657.9772,"timestamp":1774512495612,"preClose":672.622,"halted":0,"volume":212582551,"delay":0,"changeRate":-0.021773,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-14.644836,"latestTime":"03-26 16:00:00","open":672.8422,"high":691.2273,"low":655.1649,"amount":1906313878,"amplitude":0.053615,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774575000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1774488600000,1774497600000],[1774501200000,1774512000000]],"pbRate":3.590911,"peRate":140.323929,"turnoverRate":0.007865,"increases":3,"decrements":5,"flats":0,"marketCap":186976332256,"floatMarketCap":183907288544},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1617\",,,,,undefined,":{"symbol":"BK1617","high":691.2273,"amplitude":0.053615,"preClose":672.622,"low":655.1649,"pbRate":"3.590911","latestPrice":657.9772,"volume":212582551,"delay":0,"open":672.8422,"prevYearClose":701.14185,"prevWeekClose":669.975,"prevMonthClose":757.65,"prevQuarterClose":701.142,"fiveDayClose":683.403,"twentyDayClose":747.445,"sixtyDayClose":695.083,"secType":"PLATE","market":"HK","turnoverRate":0.007865,"peRate":140.323929,"marketCap":186976332256,"floatMarketCap":183907288544,"timestamp":1774512495612,"nameCN":"AI醫療"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1617\",,,,undefined,":{"bkCode":"BK1617","up":3,"down":5,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1617\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622864505","title":"《業績》微創機器人(02252.HK)全年虧損收窄至2.5億人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2622864505","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622864505?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 23:27","pubTimestamp":1774538820,"startTime":"0","endTime":"0","summary":"微创机器人-B(02252.HK) 公布2025年度业绩,收入录得5.51亿人民币(下同),按年增加114.2%。亏损由上年度6.42亿元,收窄至2.5亿元,主要由于营收增长和降本增效措施带动毛利增加、提升研发及运营效率令经营费用下降以及减值拨备减少;每股亏损24分。不派末期息。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-03-26 16:25。)过往派息公布日期派息事项派息内容2025/08/28中期业绩无派息2025/03/27末期业绩无派息2024/08/28中期业绩无派息2024/03/27末期业绩无派息AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220216125658513_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220216125658513_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1513009/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1513009/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["CNHmain","02252","CYB","BK1100","UCmain","MCNHmain","BK1617","MUCmain"],"gpt_icon":0},{"id":"2622117869","title":"智雲健康(09955)發布年度業績 收入16.23億元 毛利7.75億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622117869","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622117869?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 22:41","pubTimestamp":1774536071,"startTime":"0","endTime":"0","summary":"智通财经APP讯,智云健康 发布截至2025年12月31日止年度的年度业绩,收入16.23亿元;毛利7.75亿元;毛利率为47.8%。院外解决方案的毛利率由截至2024年12月31日止年度的23.1% 大幅增至截至2025年12月31日止年度的47.2%,主要是由于我们进行业务重组以重点打造高质量及可产生现金流的增长,导致主动减少低利润率药店增值解决方案所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1197","09955","BK1617"],"gpt_icon":0},{"id":"2622261863","title":"醫渡科技(02158)授權受託人根據股份獎勵計劃從市場購買股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2622261863","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622261863?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 21:33","pubTimestamp":1774531980,"startTime":"0","endTime":"0","summary":"智通财经APP讯,医渡科技(02158)发布公告,公司董事会已授权公司指示获委任管理首次公开发售后股份奖励计划的独立专业受托人根据首次公开发售后股份奖励计划的规则按现行市价于市场上购买公司股份。董事会认为,维持以具竞争力价格购入的股份储备,将提升集团在构建有效补偿与薪酬组合方面的灵活性,从而加强其吸引及留任集团持续增长及发展所需人才的能力。股份购买将根据公司需求并参考当前市况而作出。受托人购买的任何股份将由受托人根据公司与受托人订立的构成首次公开发售后股份奖励计划的信托契据所载明的目的及以计划规则而持有。所付金额(如有)将由公司内部财务资源拨付,将不会影响公司营运。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","BK1189","BK1617","02158"],"gpt_icon":0},{"id":"2622385078","title":"中國臨床循證智能能力建設計劃啓動 醫渡智循亮相中關村論壇年會","url":"https://stock-news.laohu8.com/highlight/detail?id=2622385078","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622385078?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 20:52","pubTimestamp":1774529552,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,3月26日,2026中关村论坛年会“世界数字健康论坛”发布一批“医疗科技创新成果”,“中国临床循证智能能力建设计划”作为其重大成果之一在会上正式启动。本次启动的“中国临床循证智能能力建设计划”正是为回应这一结构性痛点而设。在中关村论坛上启动的“中国临床循证智能能力建设计划”,不仅是一次行业协同的起点,更是中国医疗“证据驱动决策”向智能化、普惠化迈进的重要标志。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419800.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK0178","BK0075","BK1617","000931","BK0028","BK1518","02158","BK0239"],"gpt_icon":0},{"id":"2622386852","title":"愛康醫療(01789.HK)3月26日耗資718.8萬港元回購119.4萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622386852","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622386852?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 19:37","pubTimestamp":1774525023,"startTime":"0","endTime":"0","summary":"格隆汇3月26日丨爱康医疗(01789.HK)发布公告,2026年3月26日耗资718.8万港元回购119.4万股,回购价格每股6.02港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260326/32101954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1617","BK1585","01789","BK1100","BK1583"],"gpt_icon":0},{"id":"2622813834","title":"阿里健康(00241)出現大手賣出110萬股,成交價$4.7,涉資517萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2622813834","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622813834?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 15:20","pubTimestamp":1774509600,"startTime":"0","endTime":"0","summary":"[大手成交]阿里健康(00241)在下午03:20出现大手卖出,成交量为110万,成交价为港币$4.7,涉资517万。至目前为止,股价跌4.082%,今日最高价为$4.9,而最低价为$4.7,总成交量为5.355千万股,总成交金额港币$2.558亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603266539/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603266539/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1189","BK1615","BK1142","BK1247","BK1591","BK1589","00241","BK1515","BK1571","BK1584","BK1610","BK1502","BK1617","BK1501"],"gpt_icon":0},{"id":"2622839036","title":"平安好醫生(01833)股價下跌7.451%,現價港幣$11.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2622839036","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622839036?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 14:55","pubTimestamp":1774508100,"startTime":"0","endTime":"0","summary":"[下跌股]平安好医生(01833) 股价在下午03:00比前收市价下跌7.451%,现股价为港币$11.8。至目前为止,今日最高价为$11.8,而最低价为$11.8。总成交量为400股,总成交金额为港币$4720。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603264128/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603264128/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1571","BK1142","BK1219","BK1515","BK1617","BK1247","BK1615","01833"],"gpt_icon":0},{"id":"2622783996","title":"「AI製藥」的晶泰控股扭虧虛與實","url":"https://stock-news.laohu8.com/highlight/detail?id=2622783996","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622783996?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 14:52","pubTimestamp":1774507932,"startTime":"0","endTime":"0","summary":"港股“AI制药明星企业”晶泰控股交出了上市以来的首份扭亏答卷。\n2025年,晶泰控股实现营业收入8....","market":"sg","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3768447","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3768447","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"“AI制药”的晶泰控股扭亏虚与实","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","AIPO","AGIX","02228","BK1574","BK1141","BK1617","CHAT","BK1191"],"gpt_icon":0},{"id":"2622836439","title":"港股異動 | 微創機器人-B(02252)績前升逾3% 公司預計去年收入最高按年增長120%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622836439","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622836439?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 14:38","pubTimestamp":1774507106,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,微创机器人-B(02252)绩前涨超3%,截至发稿,涨3.64%,报25.06港元,成交额2.06亿港元。消息面上,微创机器人拟3月26日举行董事会会议,以考虑及通过集团截至2025年12月31日止年度的全年业绩及公布。该公司此前披露,预期公司截至2025年12月31日止年度的收入同比增长约110%至120%,经调整净亏损不超过2.40亿元,同比缩窄超过50%。收入大幅跃升主要归因于核心产品图迈®腔镜手术机器人商业化取得突破性进展,销售增长迅猛,尤其是图迈海外市场拓展成效显著,全年新签海外市场订单逾百台,全年海外市场销售收入为去年的五倍以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1100","BK4585","VXUS","02252","BK1617"],"gpt_icon":0},{"id":"2622835062","title":"AI for Science第一股晶泰控股(2228.HK)首次盈利,AI」養蝦」時代迎來收網者","url":"https://stock-news.laohu8.com/highlight/detail?id=2622835062","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622835062?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 14:22","pubTimestamp":1774506144,"startTime":"0","endTime":"0","summary":"从“养虾”到“收网”,晶泰不仅实现了自身的商业突破,更为AI行业指明方向:唯有扎根产业、解决实际痛点,才能让AI从实验室走向产业端,从烧钱工具变成真正的“产业印钞机”。","market":"us","thumbnail":"https://img2.gelonghui.com/b17e2-e0cfaa5e-109d-4095-af66-113a43a6a2c8.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-e0cfaa5e-109d-4095-af66-113a43a6a2c8.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4195672","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1141","AIPO","AGIX","CHAT","02228","BK1617"],"gpt_icon":0},{"id":"2622887959","title":"平安好醫生(01833)2025年報發出了一個關鍵信號","url":"https://stock-news.laohu8.com/highlight/detail?id=2622887959","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622887959?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 11:26","pubTimestamp":1774495564,"startTime":"0","endTime":"0","summary":"平安好医生2025年年报财报中有许多有意思的内容。根据智通财经APP的统计,32.41%的毛利率,创造了平安好医生自2018年以来的新高,彼时此一数据是27.32%;且自2023年以来,平安好医生的毛利率一直维持在30%以上的高位。在平安好医生业绩发布前后,包括花旗、美银等多家券商纷纷发布研报,看高该公司2026年的业绩成长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1142","BK1219","BK1247","BK1515","BK1615","BK1571","BK1617","01833"],"gpt_icon":0},{"id":"2622818008","title":"【券商聚焦】中信建投:醫療器械板塊拐點來臨,26年業績改善個股存在業績估值修復機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2622818008","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622818008?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 09:18","pubTimestamp":1774487918,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投表示,医疗器械板块拐点来临,26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道,以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股,未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977292","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826","BK1593","BK1574","601066","BK1571","BK1591","09997","BK1584","BK1502","BK1583","LU0173614495.USD","159883","01066","01302","BK1615","BK1142","BK1100","09996","BK1610","BK1600","02190","BK1222","02235","BK1515","BK1589","BK1585","BK1617","LU0287142896.SGD","BK1247","02252","BK1587","BK1501","BK1189","00853","BK1161","00241","BK0276"],"gpt_icon":0},{"id":"2622688504","title":"晶泰控股(02228)首次全年盈利:稀缺「AI+機器人」平台進入價值兑現期","url":"https://stock-news.laohu8.com/highlight/detail?id=2622688504","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622688504?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 08:23","pubTimestamp":1774484585,"startTime":"0","endTime":"0","summary":"3月25日,晶泰控股2025年年度业绩新鲜出炉。晶泰控股由此成为AI for Science领域首家盈利港股上市公司。“AI+机器人”平台价值迈入规模化兑现在当下外部因素干扰引发整体市场波动背景下,投资者更愿意为明确的价值兑现支付溢价。2025年,晶泰控股之所以能首次实现全年度盈利,直接驱动因素之一便在于公司药物发现解决方案业务实现长足的收入增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419201.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ROBO","02228","AGIX","CHAT","BK1141","BK1617","AIPO"],"gpt_icon":0},{"id":"2622703077","title":"愛康醫療(01789)發布年度業績 股東應占年度溢利3.39億元 按年增加23.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622703077","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622703077?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 23:10","pubTimestamp":1774451449,"startTime":"0","endTime":"0","summary":"智通财经APP讯,爱康医疗 发布截至2025年12月31日止年度业绩,该集团取得收入人民币14.82亿元,同比增加10.1%;公司权益股东应占年度溢利3.39亿元,同比增加23.8%;每股基本盈利0.304元,拟派发末期股息每股11.8港仙。2025年,在带量采购政策推动下,进一步加速进口替代,公司产品的手术量需求持续增长。本集团截至2025年12月31日止年度实现净利润人民币 3.39亿元,较2024年同期显著增长23.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1585","BK1583","BK1617","01789","BK1100"],"gpt_icon":0},{"id":"2622425071","title":"平安好醫生去年經營利潤首次轉正 AI醫生年使用人數近1200萬人","url":"https://stock-news.laohu8.com/highlight/detail?id=2622425071","media":"澎湃新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622425071?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 21:37","pubTimestamp":1774445820,"startTime":"0","endTime":"0","summary":"“现在大部分的AI企业做AI,其实是拿着锤子找钉子,我们可能是攥着票子找场子,开着车子找搭子,因为我们已经有现实、非常多的预付费场景,能结合场景开发出许多真实的产品。”3月25日,平安健康医疗科技有限公司(平安好医生,1833.HK)首席执行官何明科在2025年业绩发布会上表达了上述观点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603253684377520.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603253684377520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1247","BK1515","CHAT","BK1142","AIPO","BK1219","AGIX","01833","BK1571","BK1615","BK1617"],"gpt_icon":0},{"id":"2622027803","title":"平安好醫生2025年歸母利潤增長366.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622027803","media":"国际金融报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622027803?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 18:24","pubTimestamp":1774434283,"startTime":"0","endTime":"0","summary":"3月24日,平安健康医疗科技有限公司(01833.HK)公布2025年年度业绩报告。2025年,公司实现总收入54.68亿元,同比增长13.7%;录得归母利润3.8亿元,同比增长366.1%;调整后净利润4.14亿元,同比增长161.3%。同时,公司收入结构不断优化,商保协同业务(F端)录得收入32.96亿元,同比增长11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603253684197818.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603253684197818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1617","01833","BK1247","BK1571","BK1219","BK1515","BK1615","BK1142"],"gpt_icon":0},{"id":"2622022894","title":"XtalPi FY2025; revenue rises to CNY 803 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622022894","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622022894?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 18:19","pubTimestamp":1774433954,"startTime":"0","endTime":"0","summary":"XtalPi highlighted its Multi-Agent system as a platform capability that could strengthen differentiation in AI for Science by supporting more autonomous, end-to-end R&D workflows.The company said its AI4S 智慧解决方案 business has shifted toward platform-style enablement across sectors such as biopharma and new materials, which could broaden commercialization opportunities beyond single-solution deliveries.Revenue rose to RMB 803 million and annual profit climbed to RMB 135 million.AI4S 智慧解决方案 revenue increased to RMB 265 million, while 药物发现解决方案 revenue jumped to RMB 538 million.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xtalpi Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL6HkFs3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2622247290","title":"權益持倉超1.2萬億!「壽險頭雁」披露年報,鴻鵠基金首次「官宣」規模數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2622247290","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622247290?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 18:03","pubTimestamp":1774432992,"startTime":"0","endTime":"0","summary":"这份年报的“缝隙之处”将关键信息首次“官宣”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3768361","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3768361","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1617","02252"],"gpt_icon":0},{"id":"2622302684","title":"阿里健康與諾華達成數字化慢病合作 共建慢性蕁麻疹院外管理新模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2622302684","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622302684?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 16:37","pubTimestamp":1774427820,"startTime":"0","endTime":"0","summary":"【阿里健康与诺华达成数字化慢病合作 共建慢性荨麻疹院外管理新模式】记者3月25日获悉,阿里健康与诺华制药宣布在慢性自发性荨麻疹(CSU)领域达成数字化慢病合作。双方将围绕诺华旗下全球首个口服荨麻疹靶向药瑞米布替尼片(商品名:瑞普多),依托阿里健康的数字化平台能力,提供从疾病科普、用药指导到全周期健康管理的整合式服务。阿里健康依托其长期深耕的“全周期慢病管理体系”,为患者打造一个“院外第二诊室”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603253684062712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BJJMRZ35.SGD","NVS","BK4578","BK1617","BK1584","IE00BJT1NW94.SGD","LU0208291251.USD","BK1610","BK1515","BK4588","LU0070302665.USD","BK1189","BK1591","BK1502","IE0009355771.USD","BK1615","BK4007","BK1142","IE00B4R5TH58.HKD","00241","BK1589","BK4585","IE00BFTCPJ56.SGD","LU0211331839.USD","BK1247","BK4532","BK1501","BK1571","IE00B2B36J28.USD","IE0002141913.USD","LU0320765489.SGD"],"gpt_icon":0},{"id":"2622047089","title":"不再「單飛」後,平安好醫生變強了","url":"https://stock-news.laohu8.com/highlight/detail?id=2622047089","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622047089?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 14:52","pubTimestamp":1774421545,"startTime":"0","endTime":"0","summary":"经过前几年互联网医疗行业的野蛮生长与估值挤水后,平安好医生正试图向资本市场讲述一个全新的盈利故事。\n...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3768341","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3768341","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1142","BK1515","BK1219","BK1615","BK1617","BK1247","01833","BK1571"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":64,"code":"91000000","status":"200"}]}}